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Abstract
Background: Mycoplasma hyopneumoniae is the causative agent of enzootic pneumonia and is responsible for
significant economic losses to the pig industry. To better understand the mode of action of a commercial,
adjuvanted, inactivated whole cell vaccine and the influence of diversity on the efficacy of vaccination, we
investigated samples from vaccinated and non-vaccinated pigs experimentally infected with either a low (LV) or a
highly virulent (HV) M. hyopneumoniae strain. Non-vaccinated and sham-infected control groups were included.
Lung tissue samples collected at 4 and 8 weeks post infection (PI) were immunohistochemically tested for the
presence of T-lymphocytes, B-lymphocytes and macrophages in the bronchus-associated lymphoid tissue (BALT).
The number of M. hyopneumoniae organisms in bronchoalveolar lavage (BAL) fluid was determined using
quantitative PCR at 4 and 8 weeks PI. Serum antibodies against M. hyopneumoniae were determined at 0, 2, 4, 6
and 8 weeks PI.
Results: The immunostaining revealed a lower density of macrophages in the BALT of the vaccinated groups
compared to the non-vaccinated groups. The highest number of M. hyopneumoniae organisms in the BAL fluid
was measured at 4 weeks PI for the HV strain and at 8 weeks PI for the LV strain. Vaccination reduced the number
of organisms non-significantly, though for the HV strain the reduction was clinically more relevant than for the LV
strain. At the level of the individual pigs, a higher lung lesion score was associated with more M. hyopneumoniae
organisms in the lungs and a higher density of the investigated immune cells in the BALT.
Conclusions: In conclusion, the infiltration of macrophages after infection with M. hyopneumoniae is reduced by
vaccination. The M. hyopneumoniae replication in the lungs is also reduced in vaccinated pigs, though the HV
strain is inhibited more than the LV strain.
Background
Mycoplasma hyopneumoniae is the causative agent of
enzootic pneumonia (EP) in pigs. This disease is charac-
terized by chronic non-productive coughing and poor
growth rate and feed conversion ratio [1]. The disease
occurs worldwide and causes significant economic losses
to the pig industry [2].
The infection pattern and the severity of the disease in
pig herds can be influenced by many factors such as
management practices, housing conditions and the viru-
lence of the M. hyopneumoniae strain [3,4]. Based on
protein and genetic studies of field isolates, there
appears to be considerable diversity among this species
[5,6]. Recently, it has been shown thaQ1t within a herd
and even within a pig, different strains of M. hyopneu-
moniae can be present [7,8]. In a recent study, it was
shown that disease signs aggravated after infection with
a highly virulent (HV) strain when pigs had been pre-
viously inoculated with a low virulent (LV) strain [9].
* Correspondence: Katleen.Vranckx@telenet.be
1Department of Pathology, Bacteriology and Avian Diseases, Ghent
University, Faculty of Veterinary Medicine, Salisburylaan 133, B-9820
Merelbeke, Belgium
Full list of author information is available at the end of the article
Vranckx et al. BMC Veterinary Research 2012, 8:24
http://www.biomedcentral.com/1746-6148/8/24
© 2012 Vranckx et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
The differences in virulence between isolates may be
partly due to a differential capacity to provoke an
inflammatory response in the host [10].
The diversity between M. hyopneumoniae strains also
seems to influence the efficacy of vaccination, with bet-
ter results for some strains [11]. Previous reports have
shown that the effect of vaccination may, indeed, vary
from herd to herd. In most herds, performance losses
due to M. hyopneumoniae infection are significantly
reduced after vaccination [2]. However, there is no or
only limited effect on the transmission of this organism
[12,13].
The exact mechanisms of protection after vaccination
are not yet fully understood, although both mucosal
antibodies and cell-mediated immunity may play a part
[14]. The preferential targets of the humoral immune
response against M. hyopneumoniae are cell-surface pro-
teins, which vary between strains [7,8]. Therefore, anti-
bodies induced by vaccination, might be less effective
against infection with certain field strains [15].
Little is known about the effect of different strains on
the pig’s immune system. Meyns et al. [10] showed that
more leukocytes were found in the lung tissue and more
IL-1b and TNF-a were detected in broncho-alveolar
lavage (BAL) fluid after infection with a HV strain com-
pared to a LV strain. Although the leukocytes were not
characterized and only two cytokines were investigated,
the HV strain appeared to induce a more severe inflam-
matory response. The predominant cell types found in
the bronchus-associated lymphoid tissue (BALT) after
natural infection with M. hyopneumoniae are macro-
phages, but T-lymphocytes, B-lymphocytes and to a les-
ser extent neutrophils are also present [16].
Macrophages are important in the production of several
pro-inflammatory cytokines. These cytokines are essen-
tial in the resolution of the infection, but are also
responsible for tissue damage in the host [16-18].
In the present study, the infiltration of lung tissue
with mononuclear cells after infection of pigs with a
highly and low virulent M. hyopneumoniae strain was




The results of the scoring of the immunostaining are
presented in Table 1. When comparing the effect of
strain, no significant differences can be seen between
the nvHV and the nvLV group though the values of
macrophages, T- and B-lymphocytes were consistently
highest in the nvHV group. In the groups infected with
the HV strain, it was noticed that the scoring of T-lym-
phocytes remained high at 8 weeks post infection while
for the other groups a substantial reduction in the score
was seen. The difference between nvHV, vHV and con-
trol at 8 weeks post inoculation had p-values of 0.054
and 0.064 respectively.
At 4 weeks PI, the density of macrophages in the
BALT of the non-vaccinated groups was higher com-
pared to the vaccinated groups, though this difference
was only significant for the HV strain. At 8 weeks, no
significant differences were observed for the macro-
phages though the score in the non-vaccinated groups
remained higher than in the vaccinated groups.
Quantitative PCR
The number of M. hyopneumoniae organisms was highly
variable between individual animals, even in animals
belonging to the same group. This resulted in few signifi-
cant differences between groups, though in some cases
high numerical differences were seen (Table 1). The
highest number of M. hyopneumoniae organisms was
found in the BAL fluid of the nvHV group at four weeks
PI (Table 1). For this group, the number of organisms at
8 weeks PI was lower than at 4 weeks PI, but the opposite
was found for the nvLV group. These changes were, how-
ever, not significant (p-values: 0.076 and 0.237, respec-
tively). The values in the vaccinated groups were
Table 1 Scoring of the presence of macrophages, T- lymphocytes and B-lymphocytes in bronchus-associated lymphoid







Log of number of M. hyopneumoniae organisms in BAL
fluid (log qPCR)2
Weeks PI 4 8 4 8 4 8 4 8
control 1.0 ± 0.0 0.0 ± 0.0 0.5 ± 0.5 0.5 ± 0.5 0.0 ± 0.0a, b 0.3 ± 0.2 -0.76 ± 0.21a -0.69 ± 0.41a
nvLV 1.2 ± 0.2 0.5 ± 0.5 2.0 ± 0.5 0.8 ± 0.7 0.7 ± 0.5a, b 1.3 ± 0.8 1.25 ± 0.74a, b 2.41 ± 0.59b
nvHV 1.4 ± 0.2 1.2 ± 0.3 2.8 ± 0.2 1.6 ± 0.3 1.6 ± 0.9b 1.0 ± 0.4 3.44 ± 0.35b 1.89 ± 0.71a, b
vLV 0.8 ± 0.4 0.5 ± 0.2 1.4 ± 0.6 0.9 ± 0.2 0.0 ± 0.0a 0.1 ± 0.1 0.97 ± 0.53a, c 2.29 ± 0.39b
vHV 1.0 ± 0.3 1.0 ± 0.2 1.6 ± 0.4 1.5 ± 0.2 0.0 ± 0.0a 0.2 ± 0.1 1.96 ± 0.43b, c 1.80 ± 0.48b
nv non-vaccinated; v vaccinated; LV low virulent challenge strain; HV highly virulent challenge strain
1 Scoring was performed on samples of vaccinated and non-vaccinated pigs at 4 and 8 weeks after endotracheal inoculation with a low or highly virulent M.
hyopneumoniae strain. A non-vaccinated and non- infected control group was also included.
2 Different lowercase letters correspond to significantly different values between the groups within a column
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numerically lower than their respective non-vaccinated
groups both at 4 and 8 weeks PI. The differences for the
groups infected with the low virulent strain were much
smaller than for the groups infected with the highly viru-
lent strain. This is also reflected in the p-values. The dif-
ference between the nvHV and the vHV group at 4
weeks, when the maximum number of organisms was
observed for this strain, has a p-value of 0.099. For the
LV strain the maximum number of organisms was
observed at 8 weeks PI. The difference between the nvLV
and the vLV group at 8 weeks PI has a p-value of 0.998.
It is therefore likely that the reduction of the organisms
of the HV strain seen by vaccination reflects a true differ-
ence measured with insufficient power, but that no true
reduction is present for the LV strain.
Serology
The results of the serological testing can be found in
Table 2. Before challenge, serum antibodies against M.
hyopneumoniae were found only in the vaccinated
groups. Two weeks after challenge, a rise was seen in
the antibody titer of both the vaccinated and non-vacci-
nated groups, though the rise was more pronounced in
the vaccinated groups. At four weeks PI, all challenged
groups showed a higher titer. For the vaccinated groups
and the nvHV group, the titer remained stable after 4
weeks. Only in the nvLV group, a further rise was seen
at 6 weeks post inoculation. At all time points, the titer
in the vaccinated groups was significantly higher than
the titer in the non-vaccinated groups.
Correlations
Several correlations between the different parameters
were significantly positive or negative and the observed
associations were different between 4 and 8 weeks post
inoculation (Table 3).
Discussion
In concordance with previous studies, we observed infil-
tration of macrophages and lymphocytes in BALT after
infection with M. hyopneumoniae [16,19]. Less macro-
phages were seen in the BALT of the vaccinated pigs
compared to the non-vaccinated animals, although this
was only significant for the HV strain. This is the first
study to show such effect. Most studies on the mechan-
isms of vaccination focus on serum antibodies, neutro-
phils, lymphocytes and cytokine expression [10,20,21].
Okada et al. [22] observed a reduction of lymphocytes,
macrophages and neutrophils in the BALF of vaccinated
animals compared to non-vaccinated after experimental
infection. Thacker et al. [14] reported less TNF-a in
vaccinated animals after experimental infection with M.
hyopneumoniae. As the production of this cytokine is
induced in macrophages after contact with M. hyopneu-
moniae [23], this is in concordance with our results.
In the BAL fluid collected from the vaccinated groups,
the number of M. hyopneumoniae organisms was lower
than in the BAL fluid of the non-vaccinated groups.
This was also mentioned by Okada et al. [22]. The inhi-
bition of the growth of M. hyopneumoniae by this vac-
cine was, however, more pronounced for the HV
compared to the LV strain suggesting that vaccination
might be more effective against the HV strain. In pre-
vious studies, the onset of disease and the peak of clini-
cal symptoms was approximately two weeks later after
inoculation with the LV strain compared to the HV
strain, however the entire clinical picture remained
milder in pigs infected with the LV strain [9,11]. It is
therefore likely that the two time points included in this
trial, did not represent the peak of infection for the LV
strain. However, this fact alone cannot explain the more
pronounced reduction of organisms for the HV strain
compared to the LV strain.
Table 2 Number of pigs with serum antibodies against M. hyopneumoniae (IDEXX M. hyo Elisa) and average (± SEM) S/
P ratio at 0, 2, 4, 6 and 8 weeks post-inoculation (PI) in the different groups
Weeks PI
0 2 4 6 8
Control 0/10 0/10 0/10 0/5 0/5
0.05 ± 0.02a 0.00 ± 0.02a 0.12 ± 0.05a 0.13 ± 0.09a 0.13 ± 0.06a
nvLV 0/20 1/20 14/20 8/10 8/10
0.12 ± 0.03a 0.12 ± 0.04a 0.38 ± 0.07a, b 0.59 ± 0.12a, b 0.59 ± 0.12a
nvHV 0/20 2/20 20/20 10/10 10/10
0.15 ± 0.04a 0.12 ± 0.04a 0.61 ± 0.06b 0.68 ± 0.10b 0.67 ± 0.14a
vLV 19/20 19/20 19/10 10/10 10/10
0.45 ± 0.06b 0.84 ± 0.06b 1.11 ± 0.08c 1.20 ± 0.10c 1.24 ± 0.11b
vHV 17/20 20/20 20/20 20/20 20/20
0.46 ± 0.05b 0.86 ± 0.06b 1.14 ± 0.09c 1.24 ± 0.09c 1.26 ± 0.09b
nv non-vaccinated; v vaccinated; LV low virulent challenge strain; HV high virulent challenge strain
Different lowercase letters correspond to significantly different values between the groups at one time point Pigs were vaccinated three weeks before
inoculation
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An important first step in the innate immune
response against M. hyopneumoniae is the recognition
of mycoplasmal antigens by the TLR2/TLR-6 complex.
Though it is not the only pathway involved, the result-
ing downstream pathway leads to the stimulation of the
adaptive immune response [24]. The adaptive immune
response is responsible for the elimination of the patho-
gen. However, for M. hyopneumoniae evidence exists
that the stimulation of both innate and adaptive
immune response is also involved in lung tissue damage
[25]. We do not have any knowledge about the overall
expression patterns of cell-surface proteins of both
strains used in the present study, but it is known that
there are differences in the proteome of both strains
[26] as well as in the VNTRs (variable number of tan-
dem repeats region) of several cell-surface proteins and
hypothetical cell-surface proteins [8]. For one cell-sur-
face protein, the adhesin p97, it has been shown that at
least eight pentapeptide tandem repeats in R1 are
required to bind porcine cilia [27]. It is therefore not
unlikely that different strains have a different binding
affinity to host proteins including the TLR2/TLR6 com-
plex and thus activate this complex to a varying degree
resulting in a different disease outcome. Therefore the
resulting downstream pathways may be more important
in the stimulation of the immune response for one
strain than for another. As a recent study reported that
vaccination may reduce the expression of TLR6 [28],
this may result in a more pronounced reduction of tis-
sue damage by strains that rely more on the TLR2/
TLR6 complex to stimulate the immune response.
Though it is well known that the outcome of M. hyop-
neumoniae infections can vary considerably between
individual animals, even in experimental circumstances,
very few efforts have been made to identify the factors
influencing this outcome. In the present study, we inves-
tigated which parameters were associated with the
severity of the disease, determined by the macroscopic
and/or microscopic lung lesion score. It became clear
that a higher lung lesion score was associated with a
higher number of M. hyopneumoniae organisms in the
BALF and the presence of more immune cells in the
BALT. This association was more evident in the non-
vaccinated infected groups compared to the vaccinated
groups (data not shown). No causal relationship can be
deducted from our data, though we suggest the hypoth-
esis that more M. hyopneumoniae organisms cause a
higher infiltration of immune cells and this causes more
tissue damage leading to more severe lung lesions.
Meyns et al. [10] observed the same tendencies in an
experimental infection study with caesarean-derived
colostrums-deprived (CDCD) piglets, though only a
Table 3 Spearman correlation coefficients between the different parameters investigated in this study1
Log qPC R T- lymphocytes B- lymphocytes Macrophages IF Micro LLS Macro LLS
Antibody titer 0 -0.06 -0.06 -0.31 -0.52* 0.17 -0.02 -0.34*
0.24 -0.09 -0.03 -0.49* 0.17 0.26 0.19
weeks PI 2 0.13 0.02 -0.31 -0.53* 0.03 0.01 -0.26
0.33* 0.19 0.13 -0.37 0.15 0.33* 0.22
4 0.20 0.02 -0.11 -0.19 0.17 0.25 -0.01
0.27 0.32 0.22 -0.29 0.01 0.45** 0.20
6 - - - - - - -
0.38* 0.57* 0.42 -0.07 0.08 0.41** 0.25
8 - - - - - - -
0.43** 0.68** 0.52* -0.04 0.12 0.46** 0.29
Log qPCR 0.33 0.48* 0.63* 0.08 0.62** 0.52**
0.33 0.36 0.45 0.30* 0.28 0.39*
T- lymphocytes 0.40 0.30 0.15 0.24 0.50*
0.83** 0.37 0.15 0.66** 0.60*
B- lymphocytes 0.76** 0.02 0.56** 0.50*
0.39 0.26 0.55** 0.53*






* p < 0.05; ** p < 0.01
1 antibody titer (SP ratio of the serology), the scoring of immune cells (T-lymphocytes, B-lymphocytes and macrophages), immunofluorescence staining for M.
hyopneumoniae (IF) and the microscopic and macroscopic lung lesion score (LLS) at the level of the individual pig at 4 (top) and 8 (bottom) weeks post-infection
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small number of animals was included in this study.
Ahn et al. [29] found a clinically relevant, though non-
significant, association between the concentration of IL-
1 in the lung tissue and the microscopic lung lesion
score. The current study is the first to suggest a connec-
tion between the number of M. hyopneumoniae, the
induction of immune cells and the severity of the lung
lesions at the level of the individual pig. It should be
noted that the data from qPCR showed much stronger
correlations with the microscopic and macroscopic lung
lesions compared to IF suggesting that qPCR is more
suitable to investigate the number of organism that IF.
The titer of serum antibodies against M. hyopneumo-
niae was not associated with severity of the lung lesions
at 4 weeks post-infection, but a high titer at later time
points (6 and 8 weeks PI) was associated with a higher
density of immune cells and a higher microscopic lung
lesion score at 8 weeks PI. This not only confirms the
absence of a link between serum antibody titer and pro-
tection against infection [30], but it also suggests that a
sustained serum response is related to the continuing
presence of clinical signs.
Conclusions
Although this study was performed on a limited number
of samples, some interesting observations were made.
Our results suggest that the infiltration of macrophages
in BALT after infection with M. hyopneumoniae is
reduced by vaccination. The growth of M. hyopneumo-
niae organisms in the lungs is also reduced in vacci-
nated pigs, though the HV strain is inhibited to a higher
extent than the LV strain. This indicates that future stu-
dies should focus on the interaction between macro-
phages and lymphocytes after infection with different




Samples were obtained during a previously described
trial [11]. The study was performed after approval of the
Ethical Committee for Animal Experiments of the
Faculty of Veterinary Medicine, Ghent University.
Briefly, 90 piglets from a M. hyopneumoniae and PRRSV
free farm, were injected at one week of age with either a
one-shot commercial, adjuvanted, whole-cell vaccine (v)
(Stellamune® One, Pfizer Animal Health) or PBS (nv).
At three weeks of age, piglets were weaned and trans-
ported to the experimental facilities of the Faculty of
Veterinary Medicine, Ghent University, Belgium. After
one week, 40 pigs were inoculated with a highly virulent
(HV) M. hyopneumoniae isolate (F7.2 C), 40 with a low
virulent (LV) M. hyopneumoniae isolate (F13.10B) and
10 with sterile medium. This resulted in five groups:
nvLV, nvHV, vLV, vHV and a non-vaccinated non-
infected control group. Half of the piglets in each group
were euthanized at 4 weeks post inoculation (PI), the
remaining half at 8 weeks PI. The immunofluorescence
scoring of M. hyopneumoniae, the histopathological
scoring (microscopic lung lesion score) and the macro-
scopic lung lesion score determined in Villarreal et al.
[11] can be found in Table 4.
Immunostaining
For each group, lung tissue samples from five randomly
selected pigs were investigated at 4 and 8 weeks PI,
except for the control group, from which only two pigs
were selected. Formalin fixed and paraffin embedded
lung samples collected for histopathological examination
for the study of Villarreal et al. [11] were examined and
if available, samples containing BALT were selected for
immunostaining. The primary antibodies used were
polycolonal rabbit antibodies against human T-lympho-
cytes CD3 (Dako A0452, Heverlee, Belgium), and B-lym-
phocytes CD20 (Neo Markers RB-9013-P, Duiven, the
Netherlands) and monoclonal mouse antibodies against
macrophages MAC387 (Serotec MAC387, Oxford, UK)
[31]. The immunostaining was based on Breugelmans et
al. [32]. Briefly, antigen retrieval was performed by incu-
bating the slides in citrate buffer, microwave heating,
and cooling during 30 min at 4°C. Non-specific binding
was prevented by incubation of the slides with 30% nor-
mal rabbit serum in PBS during 30 min at room tem-
perature. Samples were then incubated for 1 hour at
room temperature with the optimal dilutions of the anti-
bodies in PBS (CD20 and MAC387) or tris-buffered sal-
ine (CD3). After washing, the endogenous peroxidase
activity was blocked by incubation at room temperature
in 3% H2O2 for 5 min. After washing with the buffer
solution, the sections were incubated with a labelled
polymer-HRP goat anti-rabbit (CD3 and CD20) or goat
anti-mouse (MAC387) for 30 min at room temperature.
The peroxidase activity was revealed by using diamino-
benzidine (Dako, Denmark) as chromogen after washing
of the sections. The slides were counterstained with
hematoxylin for 10 s. After dehydration, the slides were
mounted using DPX mountant (VWR Int., Lutterworth,
Leicestershire, UK).
Ten images were taken per sample by standard light
microscopy at a magnification of 40× (Leitz, New York,
USA), covering the whole surface area of the slide. A
visual score according to the density of stained cells in
the BALT was assigned ranging from 0 (no to a few
stained cells) to 3 (almost all cells in BALT stained). All
images were scored by the same person and this person
was blinded to the groups.
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Quantitative PCR
The number of M. hyopneumoniae organisms in the
lung was estimated by performing quantitative PCR
(qPCR) on the BAL fluid as described previously [33].
Briefly, qPCR was performed with primers 5’
GTCAAAGTCAAAGTCAGCAAAC 3’and 5’
AGCTGTTCAAATGCTTGTCC 3’ using iQ SYBR
Green Supermix (Bio-Rad, Eke Nazareth, Belgium) in
the CFX96 real-time PCR detection system (Bio-Rad).
To convert the threshold values to the number of
organisms, a tenfold dilution series of M. hyopneumo-
niae DNA was made in PBS.
Serology
At 0, 2, 4, 6 and 8 weeks PI, blood samples were taken
from all pigs and tested for the presence of antibodies
against M. hyopneumoniae in the serum using the
IDEXX M. hyo. ELISA (IDEXX, Hoofddorp, The Neth-
erlands). The serum antibody titer is estimated by the
sample-to-positive (SP) ratios calculated from the optical
density (OD)-values: (ODsample - average ODneg control)/
(average ODpos control - average ODneg control) [34].
Statistical analysis
One-way analysis of variance (ANOVA) was used to
analyze the results from the scoring of immunostaining,
qPCR and the serum antibody titer between groups at
the same time point. When the homogeneity of var-
iances test was passed, Bonferroni was used as post hoc
test, when it failed, Dunnett T3 was used. Data from
qPCR was transformed to the logarithm prior to analysis
to normalize the data. Correlations between macro-
scopic lung lesion score, microscopic lung lesion score
(histopathology), IF, immunostaining, log qPCR and
serum antibody titer on the level of the individual pig
were determined by calculating the Spearman’s rho cor-
relation score (r) both for the data 4 and 8 weeks PI.
Correlations were also calculated for these three para-
meters and the antibody titer at and before euthanasia
for both 4 and 8 weeks PI. The statistical results were
considered significant when p-values were ≤ 0.05. All
analyses were performed with SPSS 17.0 for Windows
(SPSS inc. Illinois, USA).
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